We recently published a list of Jim Cramer’s Thoughts on These 7 Stocks. In this article, we are going to take a look at where RadNet, Inc. (NASDAQ:RDNT) stands against other stocks that Jim Cramer has shared his thoughts on.
Jim Cramer, the host of Mad Money, recently revisited one of his core investment principles: “Nobody ever made a dime panicking.” He emphasized that, no matter how many times he has shared this advice, it always feels as crucial as the first time. Observing the current turmoil in tech stocks, Cramer pointed out that panic selling leads to missing out on the recovery that often follows. Specifically, he noted how those who sold their tech holdings this week missed the subsequent surge in tech stocks that delivered strong returns.
READ ALSO: Jim Cramer Looked At These 7 Stocks Recently and 7 Stocks on Jim Cramer’s Radar
Cramer explained that the panic was so widespread that it even affected the stocks of companies that were benefiting from the tech boom. He observed that even when good news was on the horizon, fear caused investors to make rushed decisions. He then discussed how a Chinese company recently announced a new innovation suggesting that fewer NVDA chips are needed for artificial intelligence applications.
“The companies that are doing well might even do better if DeepSeek’s formula for success spreads, bunch of knuckleheads.”
While Cramer acknowledged that this new technology, such as DeepSeek’s offering, posed a potential threat to NVDA, he quickly said, “The way I see it, that’s nonsense.” However, Cramer was particularly critical of how the market reacted to this news. He pointed out that the panic was so intense that even companies benefiting from the tech sector’s growth were dragged down.
“Here’s the bottom line: The shoot first ask-questions-later approach works when there’s fraud or chicanery and we know we must sell but when things are complicated or murky, it might not make sense to help create the biggest single-day dollar loss in history, chums. There’s a better way. Just don’t do anything. If you really wanna sell, you can do it into the rebound the next day. In my experience, after one more dip in the morning, you almost always get a better price.”
Our Methodology
For this article, we compiled a list of 7 stocks that were discussed by Jim Cramer during the episodes of Mad Money aired on January 28 and 30. We listed the stocks in ascending order of their hedge fund sentiment as of the third quarter, which was taken from Insider Monkey’s database of 900 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A radiologist studying a monitor with a detailed image of a lung cancer tumor.
RadNet, Inc. (NASDAQ:RDNT)
Number of Hedge Fund Holders: 20
A caller noted the dip in RadNet, Inc. (NASDAQ:RDNT) stock and asked if they should take advantage of it. Here’s what Cramer said:
“Well, I’d like to see some sort of, I mean, the stock did bounce $2 today… It’s a very expensive stock. I’ve been, I’m trying to sell… GE HealthCare if I can just because I kind of just feel this group is just not strong enough, that includes this one. Let’s give it a pause for a second. Let’s see if it can’t bottom for more than just one particular day. But I understand it was a great stock for a long time. I need to see a real bottom.”
RadNet (NASDAQ:RDNT) provides outpatient diagnostic imaging services and develops advanced imaging technologies, including AI solutions to improve radiology interpretations and support cancer screening. Cramer has called RDNT stock expensive before in 2023 as he said:
“We opined positively about RadNet before, diagnostic company, and I think it’s too expensive versus GE Healthcare, which we own for the trust…it sells at 21 times earnings, and is much more connected with what Biogen and Eli Lilly are doing when it comes to Alzheimer’s and dementia.”
Overall, RDNT ranks 7th on our list of stocks that Jim Cramer has shared his thoughts on. While we acknowledge the potential of RDNT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RDNT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article is originally published at Insider Monkey.
Hedge Fund Resource Center